{"timestamp": 1771602981.154248, "value": {"ticker": "AKBA", "company_name": "Akebia Therapeutics, Inc.", "short_name": "Akebia Therapeutics, Inc.", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "country": "United States", "market_cap": 306497728, "float_shares": 259761463, "shares_outstanding": 265365993, "short_ratio": 12.53, "short_percent_of_float": 0.14060001, "shares_short": 36927875, "shares_short_prior": 36058633, "insider_percent_held": 0.04235, "institution_percent_held": 0.47949, "total_cash": 166444000, "total_debt": 199008000, "total_revenue": 225071008, "revenue_growth": 0.57, "earnings_growth": 0, "profit_margins": -0.07067, "gross_margins": 0.83319, "operating_margins": 0.07571, "debt_to_equity": 478.477, "current_ratio": 1.937, "book_value": 0.157, "price_to_book": 7.3566875, "operating_cashflow": 32397000, "free_cashflow": 50708500, "price": 1.155, "52w_high": 4.079, "52w_low": 1.14, "avg_volume": 3300510, "avg_volume_10d": 4425060, "full_time_employees": 181, "audit_risk": 10, "overall_risk": 8}}